Information for COVID-19 Therapeutics Providers

Texas Case Counts microscopic example of a coronavirus

This page contains information and resources for Texas COVID-19 therapeutics providers. Providers with questions can contact therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.

On this page:


News & Updates

Update on Therapeutics and the Omicron Variant

See the 1/20/22 DSHS letter to therapeutics providers for an update on COVID-19 therapeutics and the Omicron variant.

More Provider Notices

Weekly eDigests (PDFs)


How to Become a COVID-19 Therapeutics Provider

To order COVID-19 therapeutics, providers must have an AmerisourceBergen Account and have access to the Vaccine Allocation Ordering System (VAOS).

For more information on the enrollment process, please review the COVID-19 Therapeutics Enrollment Guide (PDF).

If you have any questions or issues, please email therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.


Therapeutics Products

Click on any of the buttons below to access a list of product-specific resources.

For the latest information on product distribution across the state, see the Texas COVID-19 Product Availability section.

Monoclonal Antibody (mAb) Products

Bamlanivimab + Etesevimab (Lilly) Casirivimab + Imdevimab (Regeneron) Sotrovimab (GlaxoSmithKline)

Long-Acting Antibody (LAAB) Product

Evusheld: tixagevimab + cilgavimab (AstraZeneca)

Oral Antiviral Products

Molnupiravir (Merck) Paxlovid: nirmatrelvir + ritonavir (Pfizer)


Provider Resources & Training

Important Links

Job Aids & FAQs

Webinars


Texas COVID-19 Product Availability


Billing & Coding Information

▲ Top


This page is being updated as new information becomes available.

Last updated January 21, 2022